![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
norUrsodeoxycholic acid (norUDCA) improves
non-alcoholic fatty liver disease (NAFLD):
Results from a randomized placebo-controlled,
double-blind phase IIa study
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
S. Traussnigg, J. M. Schattenberg, M. Demir, J. Wiegand, A. Geier, G. Teuber, W. P. Hofmann, A. E. Kremer, F. Spreda, J. Kluwe, J. Petersen, T. Boettler, E. Halilbasic, R. Greinwald, M. Proels, M. P. Manns, P. Fickert, M. Trauner
![1113171](../images/111317/111317-9/1113171.gif)
![1113172](../images/111317/111317-9/1113172.gif)
![1113173](../images/111317/111317-9/1113173.gif)
![1113174](../images/111317/111317-9/1113174.gif)
![1113175](../images/111317/111317-9/1113175.gif)
![1113176](../images/111317/111317-9/1113176.gif)
![1113177](../images/111317/111317-9/1113177.gif)
![1113178](../images/111317/111317-9/1113178.gif)
![1113179](../images/111317/111317-9/1113179.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|